PDGFRA
MOLECULAR TARGETplatelet derived growth factor receptor alpha
PDGFRA (platelet derived growth factor receptor alpha) is targeted by 61 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PDGFRA
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | erlotinib | 5.55 | 256 |
| 2 | imatinib | 5.47 | 236 |
| 3 | alvocidib | 4.52 | 91 |
| 4 | foretinib | 4.34 | 76 |
| 5 | tozasertib | 4.33 | 75 |
| 6 | vandetanib | 4.30 | 73 |
| 7 | ponatinib | 4.26 | 70 |
| 8 | ceritinib | 4.19 | 65 |
| 9 | nilotinib | 4.17 | 64 |
| 10 | bosutinib | 4.08 | 58 |
| 11 | doramapimod | 4.06 | 57 |
| 12 | quizartinib | 3.99 | 53 |
| 13 | semaxanib | 3.93 | 50 |
| 14 | midostaurin | 3.85 | 46 |
| 15 | pazopanib | 3.69 | 39 |
| 16 | vatalanib | 3.69 | 39 |
| 17 | nintedanib | 3.61 | 36 |
| 18 | regorafenib | 3.56 | 34 |
| 19 | canertinib | 3.53 | 33 |
| 20 | tae 684 | 3.43 | 30 |
| 21 | pexidartinib | 3.43 | 30 |
| 22 | fedratinib | 3.40 | 29 |
| 23 | bms 777607 | 3.37 | 28 |
| 24 | linifanib | 3.33 | 27 |
| 25 | mln 8054 | 3.33 | 27 |
| 26 | saracatinib | 3.33 | 27 |
| 27 | neflamapimod | 3.30 | 26 |
| 28 | tandutinib | 3.22 | 24 |
| 29 | dovitinib | 3.09 | 21 |
| 30 | jnj 7706621 | 3.09 | 21 |
| 31 | at 9283 | 3.09 | 21 |
| 32 | lestaurtinib | 3.04 | 20 |
| 33 | lenvatinib | 3.04 | 20 |
| 34 | defosbarasertib | 2.89 | 17 |
| 35 | barasertib | 2.89 | 17 |
| 36 | r 406 | 2.83 | 16 |
| 37 | cediranib | 2.83 | 16 |
| 38 | infigratinib | 2.77 | 15 |
| 39 | masitinib | 2.77 | 15 |
| 40 | pha 665752 | 2.71 | 14 |
| 41 | plx 4720 | 2.71 | 14 |
| 42 | crenolanib | 2.71 | 14 |
| 43 | enmd 2076 | 2.71 | 14 |
| 44 | kw 2449 | 2.64 | 13 |
| 45 | tivozanib | 2.64 | 13 |
| 46 | bemcentinib | 2.64 | 13 |
| 47 | ast 487 | 2.56 | 12 |
| 48 | raf 265 | 2.48 | 11 |
| 49 | motesanib | 2.48 | 11 |
| 50 | brivanib | 2.48 | 11 |
Showing top 50 of 61 compounds. Use the BiohacksAI search to explore all PDGFRA modulators.
About PDGFRA as a Drug Target
PDGFRA (platelet derived growth factor receptor alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 61 compounds with documented PDGFRA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PDGFRA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.